Per-protocol analysis confirmed these results (P = 0.03). Stool volume was consistently higher in the neostigmine group during the 7-day observational period (all P < 0.05). Other secondary outcomes were not significantly different between neostigmine and convent
…Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1945 | 4 |
1946 | 41 |
1947 | 36 |
1948 | 42 |
1949 | 20 |
1950 | 40 |
1951 | 56 |
1952 | 47 |
1953 | 41 |
1954 | 47 |
1955 | 53 |
1956 | 46 |
1957 | 37 |
1958 | 36 |
1959 | 21 |
1960 | 22 |
1961 | 21 |
1962 | 36 |
1963 | 101 |
1964 | 126 |
1965 | 101 |
1966 | 109 |
1967 | 117 |
1968 | 132 |
1969 | 111 |
1970 | 121 |
1971 | 133 |
1972 | 128 |
1973 | 131 |
1974 | 129 |
1975 | 111 |
1976 | 99 |
1977 | 91 |
1978 | 77 |
1979 | 100 |
1980 | 107 |
1981 | 97 |
1982 | 112 |
1983 | 97 |
1984 | 99 |
1985 | 110 |
1986 | 102 |
1987 | 96 |
1988 | 108 |
1989 | 121 |
1990 | 79 |
1991 | 80 |
1992 | 90 |
1993 | 104 |
1994 | 99 |
1995 | 94 |
1996 | 99 |
1997 | 91 |
1998 | 92 |
1999 | 90 |
2000 | 85 |
2001 | 75 |
2002 | 62 |
2003 | 71 |
2004 | 60 |
2005 | 81 |
2006 | 79 |
2007 | 65 |
2008 | 70 |
2009 | 92 |
2010 | 88 |
2011 | 96 |
2012 | 87 |
2013 | 107 |
2014 | 93 |
2015 | 99 |
2016 | 117 |
2017 | 103 |
2018 | 108 |
2019 | 108 |
2020 | 122 |
2021 | 118 |
2022 | 133 |
2023 | 17 |
Search Results
6,464
results
Results by year
Page 1
Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis.
Crit Care. 2022 Mar 3;26(1):52. doi: 10.1186/s13054-022-03922-4.
Crit Care. 2022.
PMID: 35241135
Free PMC article.
Clinical Trial.
Per-protocol analysis confirmed these results (P = 0.03). Stool volume was consistently higher in the neostigmine group during the 7- …
Neostigmine Hyperinflation.
J Pharm Pract. 2018 Aug;31(4):395-398. doi: 10.1177/0897190018762884. Epub 2018 Mar 11.
J Pharm Pract. 2018.
PMID: 29528806
No abstract available.
Neostigmine methylsulfate. Does it have a chronic effect as well as a transient one?
Arch Neurol. 1975 Dec;32(12):808-13. doi: 10.1001/archneur.1975.00490540052006.
Arch Neurol. 1975.
PMID: 173268
Three groups of 200-gm rats were injected subcutaneously with neostigmine methylsulfate (1 mg/kg/day) for 7, 30, and 100 days. Electrophysiological changes were assessed in vitro, using microelectrode techniques to examine diaphragm muscles of treated and untreated …
Three groups of 200-gm rats were injected subcutaneously with neostigmine methylsulfate (1 mg/kg/day) for 7, 30, and 100 days. …
Neostigmine methylsulfate therapy in hemiplegia.
Arch Neurol Psychiatry. 1949 Jul;62(1):93-8. doi: 10.1001/archneurpsyc.1949.02310130099006.
Arch Neurol Psychiatry. 1949.
PMID: 18147411
No abstract available.
The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.
Anaesthesia. 2018 May;73(5):631-641. doi: 10.1111/anae.14160. Epub 2017 Dec 27.
Anaesthesia. 2018.
PMID: 29280475
Free article.
There were significantly fewer composite adverse events in the sugammadex group compared with neostigmine, with a risk ratio (95%CI) of 0.60 (0.49-0.74) (I(2) = 40%, 28 studies, n = 2298, number needed to treat (NNT): 8, GRADE: moderate quality). ...Sugammadex reverses neu …
There were significantly fewer composite adverse events in the sugammadex group compared with neostigmine, with a risk ratio (95%CI) …
Neostigmine for reversal of neuromuscular block in paediatric patients.
Cochrane Database Syst Rev. 2014 May 5;(5):CD010110. doi: 10.1002/14651858.CD010110.pub2.
Cochrane Database Syst Rev. 2014.
PMID: 24793636
Review.
Therefore, whether neostigmine should be used routinely to reverse neuromuscular blockade in each paediatric patient is an important question for paediatric anaesthesiologists. ...AUTHORS' CONCLUSIONS: No RCTs were found that supported, or argued against, the routine use o …
Therefore, whether neostigmine should be used routinely to reverse neuromuscular blockade in each paediatric patient is an important …
Obituary: neostigmine, the consequences of a premature loss.
Minerva Anestesiol. 2022 Mar;88(3):203-205. doi: 10.23736/S0375-9393.21.16288-1.
Minerva Anestesiol. 2022.
PMID: 35315630
Free article.
No abstract available.
Neostigmine-resistant curarization.
Br Med J. 1956 Oct 20;2(4998):919-21. doi: 10.1136/bmj.2.4998.919.
Br Med J. 1956.
PMID: 13364356
Free PMC article.
No abstract available.
Neostigmine toxicity.
J Am Med Assoc. 1948 Jul 17;137(12):1078. doi: 10.1001/jama.1948.02890460074020.
J Am Med Assoc. 1948.
PMID: 18871862
No abstract available.
The clinical utility of neostigmine administration in the diagnosis of acquired myasthenia gravis.
J Vet Emerg Crit Care (San Antonio). 2021 Sep;31(5):647-655. doi: 10.1111/vec.13097. Epub 2021 Jul 29.
J Vet Emerg Crit Care (San Antonio). 2021.
PMID: 34324776
OBJECTIVE: To assess the clinical utility of neostigmine methylsulfate administration in the diagnosis of suspected acquired myasthenia gravis (MG) in dogs and cats. ...MEASUREMENTS & MAIN RESULTS: The route of neostigmine administration was recorded. Res …
OBJECTIVE: To assess the clinical utility of neostigmine methylsulfate administration in the diagnosis of suspected acquired m …
Cite